Neoadjuvant treatment of pancreatic ductal adenocarcinoma

被引：1

作者：

Kosma, Katharina ^{[1
]}

Thalhammer, Sabine ^{[1
]}

Gruenberger, Thomas ^{[1
]}

机构：

[1] Clin Favoriten, Dept Surg, Hepatopancreatobiliary Ctr, Hlth Network Vienna, Kundratstr 3, A-1100 Vienna, Austria

来源：

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2022年 / 15卷 / 03期

关键词：

Borderline resectable pancreatic cancer; Resectable pancreatic cancer; Neoadjuvant; Induction therapy; Surgery; Overall survival; ADJUVANT CHEMOTHERAPY; UPFRONT SURGERY; CANCER; THERAPY; CHEMORADIATION; COMPLICATIONS;

D O I：

10.1007/s12254-022-00832-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant therapy in resectable and borderline resectable pancreatic cancer is the subject of several ongoing randomized controlled trials (RCTs). Retrospective studies and completed RCTs favor the use of neoadjuvant therapy in pancreatic cancer. Yet, the optimal chemotherapy regimen has not been defined. The objective of this report is to provide a review of currently available study data of neoadjuvant therapy in pancreatic cancer.

引用

页码：219 / 223

页数：5

共 33 条

[1] Surgical Outcome Results From SWOG S1505 A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma [J].

Ahmad, Syed A. ;

Duong, Mai ;

Sohal, Davendra P. S. ;

Gandhi, Namita S. ;

Beg, Muhammad Shaalan ;

Wang-Gillam, Andrea ;

Wade, James L., III ;

Chiorean, Elena Gabriela ;

Guthrie, Katherine A. ;

Lowy, Andrew M. ;

Philip, Philip A. ;

Hochster, Howard S. .

ANNALS OF SURGERY, 2020, 272 (03) :481-486

[2] Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) [J].

Arcelli, Alessandra ;

Buwenge, Milly ;

Macchia, Gabriella ;

Bertini, Federica ;

Guido, Alessandra ;

Deodato, Francesco ;

Cilla, Savino ;

Scotti, Valerio ;

Rosetto, Maria Elena ;

Djan, Igor ;

Parisi, Salvatore ;

Mattiucci, Gian Carlo ;

Cellini, Francesco ;

Fiore, Michele ;

Bonomo, Pierluigi ;

Belgioia, Liliana ;

Niespolo, Rita Marina ;

Gabriele, Pietro ;

Di Marco, Mariacristina ;

Simoni, Nicola ;

Mazzarotto, Renzo ;

Morganti, Alessio Giuseppe .

CANCER MEDICINE, 2020, 9 (21) :7879-7887

[3] The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis [J].

Bakens, Maikel J. ;

van der Geest, Lydia G. ;

van Putten, Magreet ;

van Laarhoven, Hanneke W. ;

Creemers, Geert-Jan ;

Besselink, Marc G. ;

Lemmens, Valery E. ;

de Hingh, Ignace H. .

CANCER MEDICINE, 2016, 5 (10) :2825-2831

[4] Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions [J].

Brunner, Maximilian ;

Wu, Zhiyuan ;

Krautz, Christian ;

Pilarsky, Christian ;

Gruetzmann, Robert ;

Weber, Georg F. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)

[5] Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets [J].

Casadei, Riccardo ;

Di Marco, Mariacristina ;

Ricci, Claudio ;

Santini, Donatella ;

Serra, Carla ;

Calculli, Lucia ;

D'Ambra, Marielda ;

Guido, Alessandra ;

Morselli-Labate, Antonio Maria ;

Minni, Francesco .

JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (10) :1802-1812

[6] Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials [J].

Cloyd, Jordan M. ;

Heh, Victor ;

Pawlik, Timothy M. ;

Ejaz, Aslam ;

Dillhoff, Mary ;

Tsung, Allan ;

Williams, Terence ;

Abushahin, Laith ;

Bridges, John F. P. ;

Santry, Heena .

JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)

[7] Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas. [J].

Conroy, Thierry ;

Hammel, Pascal ;

Hebbar, Mohamed ;

Ben Abdelghani, Meher ;

Wei, Alice Chia-chi ;

Raoul, Jean-Luc ;

Chone, Laurence ;

Francois, Eric ;

Artru, Pascal ;

Biagi, James Joseph ;

Lecomte, Thierry ;

Assenat, Eric ;

Faroux, Roger ;

Ychou, Marc ;

Volet, Julien ;

Sauvanet, Alain ;

Jouffroy-Zeller, Claire ;

Rat, Patrick ;

Castan, Florence ;

Bachet, Jean-Baptiste .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)

[8] The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers [J].

Dyba, Tadeusz ;

Randi, Giorgia ;

Bray, Freddie ;

Martos, Carmen ;

Giusti, Francesco ;

Nicholson, Nicholas ;

Gavin, Anna ;

Flego, Manuela ;

Neamtiu, Luciana ;

Dimitrova, Nadya ;

Carvalho, Raquel Negrao ;

Ferlay, Jacques ;

Bettio, Manola .

EUROPEAN JOURNAL OF CANCER, 2021, 157 :308-347

[9] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group [J].

Ettrich, Thomas J. ;

Berger, Andreas W. ;

Perkhofer, Lukas ;

Daum, Severin ;

Koenig, Alexander ;

Dickhut, Andreas ;

Wittel, Uwe ;

Wille, Kai ;

Geissler, Michael ;

Alguel, Hana ;

Gallmeier, Eike ;

Atzpodien, Jens ;

Kornmann, Marko ;

Muche, Rainer ;

Prasnikar, Nicole ;

Tannapfel, Andrea ;

Reinacher-Schick, Anke ;

Uhl, Waldemar ;

Seufferlein, Thomas .

BMC CANCER, 2018, 18

[10]

Golcher H, 2015, STRAHLENTHER ONKOL, V191, P7, DOI 10.1007/s00066-014-0737-7

← 1 2 3 4 →